Lumicell Drug Patent Portfolio
Lumicell owns 1 orange book drug protected by 5 US patents Given below is the list of Lumicell's drug patents along with their expiration dates.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US9763577 | Imaging agent for detection of diseased cells | 14 Sep, 2034 | Active |
US10285759 | Methods and system for image guided cell ablation with microscopic resolution | 08 Dec, 2031 | Active |
US9032965 | Methods and system for image guided cell ablation with microscopic resolution | 08 Dec, 2031 | Active |
US9532835 | Methods and system for image guided cell ablation with microscopic resolution | 08 Dec, 2031 | Active |
US9155471 | Methods and systems for spatially identifying abnormal cells | 12 Oct, 2031 | Active |
Latest Legal Activities on Lumicell's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Lumicell.
Activity | Date | Patent Number |
---|---|---|
Payment of Maintenance Fee, 8th Yr, Small Entity | 03 Jul, 2024 | US9532835 |
Email Notification
Critical
| 21 Jun, 2024 | US9763577 |
Change in Power of Attorney (May Include Associate POA)
Critical
| 21 Jun, 2024 | US9763577 |
Patent Term Extension Application under 35 USC 156 Filed | 14 Jun, 2024 | US9763577 |
Payment of Maintenance Fee, 8th Yr, Small Entity | 13 Apr, 2023 | US9155471 |
Surcharge for late Payment, Small Entity | 13 Feb, 2023 | US10285759 |
Payment of Maintenance Fee, 8th Yr, Small Entity | 13 Feb, 2023 | US9032965 |
Payment of Maintenance Fee, 4th Yr, Small Entity | 13 Feb, 2023 | US10285759 |
7.5 yr surcharge - late pmt w/in 6 mo, Small Entity | 13 Feb, 2023 | US9032965 |
Maintenance Fee Reminder Mailed
Critical
| 09 Jan, 2023 | US9032965 |
Maintenance Fee Reminder Mailed
Critical
| 02 Jan, 2023 | US10285759 |
Payment of Maintenance Fee, 4th Yr, Small Entity | 19 Mar, 2021 | US9763577 |
Payment of Maintenance Fee, 4th Yr, Small Entity | 06 Jul, 2020 | US9532835 |
Patent Issue Date Used in PTA Calculation
Critical
| 14 May, 2019 | US10285759 |
Recordation of Patent Grant Mailed
Critical
| 14 May, 2019 | US10285759 |
Lumicell's Family Patents
Lumicell Drug List
Given below is the complete list of Lumicell's drugs and the patents protecting them.
1. Lumisight
Lumisight is protected by 5 patents, out of which none have expired yet. Check out its patent list below.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US9763577 | Imaging agent for detection of diseased cells |
14 Sep, 2034
(9 years from now)
| Active |
US10285759 | Methods and system for image guided cell ablation with microscopic resolution |
08 Dec, 2031
(7 years from now)
| Active |
US9032965 | Methods and system for image guided cell ablation with microscopic resolution |
08 Dec, 2031
(7 years from now)
| Active |
US9532835 | Methods and system for image guided cell ablation with microscopic resolution |
08 Dec, 2031
(7 years from now)
| Active |
US9155471 | Methods and systems for spatially identifying abnormal cells |
12 Oct, 2031
(6 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Lumisight's drug page